HRP20020302B1 - Calcium complex of phosphorus containing ethylenediamine derivatives - Google Patents

Calcium complex of phosphorus containing ethylenediamine derivatives

Info

Publication number
HRP20020302B1
HRP20020302B1 HR20020302A HRP20020302A HRP20020302B1 HR P20020302 B1 HRP20020302 B1 HR P20020302B1 HR 20020302 A HR20020302 A HR 20020302A HR P20020302 A HRP20020302 A HR P20020302A HR P20020302 B1 HRP20020302 B1 HR P20020302B1
Authority
HR
Croatia
Prior art keywords
kappa
calcium complex
phosphorus containing
containing ethylenediamine
ethylenediamine derivatives
Prior art date
Application number
HR20020302A
Other languages
English (en)
Inventor
Platzek Johannes
Niedballa Ulrich
Michl Guenter
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7922563&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20020302(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE1999144893 external-priority patent/DE19944893C2/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of HRP20020302A2 publication Critical patent/HRP20020302A2/hr
Publication of HRP20020302B1 publication Critical patent/HRP20020302B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/117Esters of phosphoric acids with cycloaliphatic alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/101Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/04Chelating agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
HR20020302A 1999-09-09 2002-04-09 Calcium complex of phosphorus containing ethylenediamine derivatives HRP20020302B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1999144893 DE19944893C2 (de) 1999-09-09 1999-09-09 Calcium-Komplex von [[(4R)-4-[bis[(carboxy-.kappa.O)methyl]amino-. kappa.N]-6,9-bis[(carboxy-.kappa.O)methyl]-1-[(4,4-diphenylcyclohexyl)oxy]-1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan-11-yl-säure-.kappa.N6, .kappa.N9,.kappa.O11]1-oxidato(6-)]-, hexahydrogen, dessen Salze und diese Komplexe enthaltende pharmazeutische Mittel
PCT/EP2000/008694 WO2001018011A1 (en) 1999-09-09 2000-09-06 Calcium complex of phosphorus containing ethylenediamine derivatives

Publications (2)

Publication Number Publication Date
HRP20020302A2 HRP20020302A2 (en) 2004-02-29
HRP20020302B1 true HRP20020302B1 (en) 2005-08-31

Family

ID=7922563

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20020302A HRP20020302B1 (en) 1999-09-09 2002-04-09 Calcium complex of phosphorus containing ethylenediamine derivatives

Country Status (30)

Country Link
EP (1) EP1210353B1 (sh)
JP (1) JP2003508537A (sh)
KR (1) KR100650090B1 (sh)
CN (1) CN100341883C (sh)
AT (1) ATE245159T1 (sh)
AU (1) AU783982B2 (sh)
BG (1) BG65280B1 (sh)
BR (1) BR0013871A (sh)
CA (1) CA2380766C (sh)
CZ (1) CZ2002834A3 (sh)
DE (2) DE19964224B4 (sh)
DK (1) DK1210353T3 (sh)
EE (1) EE05106B1 (sh)
ES (1) ES2202178T3 (sh)
HK (1) HK1050202A1 (sh)
HR (1) HRP20020302B1 (sh)
HU (1) HUP0202873A3 (sh)
IL (1) IL148563A (sh)
MX (1) MXPA02001583A (sh)
NO (1) NO20021167D0 (sh)
NZ (1) NZ517708A (sh)
PL (1) PL354749A1 (sh)
PT (1) PT1210353E (sh)
RS (1) RS50125B (sh)
RU (1) RU2247727C2 (sh)
SK (1) SK3242002A3 (sh)
TW (1) TWI263641B (sh)
UA (1) UA74165C2 (sh)
WO (1) WO2001018011A1 (sh)
ZA (1) ZA200202742B (sh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201514188A (zh) * 2013-03-13 2015-04-16 Lantheus Medical Imaging Inc 製備釓磷維塞三鈉單水合物之方法
CN114845990A (zh) 2019-12-20 2022-08-02 伯拉考成像股份公司 钙bopta配合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3129906C3 (de) * 1981-07-24 1996-12-19 Schering Ag Paramagnetische Komplexsalze, deren Herstellung und Mittel zur Verwendung bei der NMR-Diagnostik
TW319763B (sh) * 1995-02-01 1997-11-11 Epix Medical Inc
US5919967A (en) * 1997-04-11 1999-07-06 Epix Medical, Inc. Process for synthesizing phosphodiesters

Also Published As

Publication number Publication date
DE19964224B4 (de) 2005-09-01
ES2202178T3 (es) 2004-04-01
SK3242002A3 (en) 2002-10-08
JP2003508537A (ja) 2003-03-04
HK1050202A1 (en) 2003-06-13
YU16102A (sh) 2005-06-10
WO2001018011A1 (en) 2001-03-15
IL148563A (en) 2005-12-18
KR100650090B1 (ko) 2006-11-27
HUP0202873A2 (hu) 2002-12-28
EE05106B1 (et) 2008-12-15
WO2001018011A9 (en) 2002-09-06
DE60003931T2 (de) 2004-05-27
EE200200090A (et) 2003-04-15
DE60003931D1 (de) 2003-08-21
ATE245159T1 (de) 2003-08-15
DE19964224A1 (de) 2001-06-28
CN100341883C (zh) 2007-10-10
CA2380766A1 (en) 2001-03-15
IL148563A0 (en) 2002-09-12
KR20020025256A (ko) 2002-04-03
EP1210353A1 (en) 2002-06-05
RS50125B (sr) 2009-03-25
NZ517708A (en) 2003-10-31
CA2380766C (en) 2008-11-25
CZ2002834A3 (cs) 2002-07-17
BR0013871A (pt) 2002-05-21
AU7774900A (en) 2001-04-10
AU783982B2 (en) 2006-01-12
NO20021167L (no) 2002-03-08
PL354749A1 (en) 2004-02-23
CN1373765A (zh) 2002-10-09
HUP0202873A3 (en) 2003-12-29
MXPA02001583A (es) 2004-04-05
BG106488A (en) 2002-10-31
BG65280B1 (bg) 2007-11-30
ZA200202742B (en) 2003-09-23
DK1210353T3 (da) 2003-10-27
HRP20020302A2 (en) 2004-02-29
NO20021167D0 (no) 2002-03-08
PT1210353E (pt) 2003-11-28
TWI263641B (en) 2006-10-11
RU2247727C2 (ru) 2005-03-10
EP1210353B1 (en) 2003-07-16
UA74165C2 (uk) 2005-11-15

Similar Documents

Publication Publication Date Title
TNSN98203A1 (fr) Derives de thienopyrimidine et tienopyridine utiles comme agents anticancereux, et compositions les contenant
AU4925199A (en) Quinolin-2-one derivatives useful as anticancer agents
MX9503529A (es) Derivados de glicinamida, procedimiento para su preparacion y medicamentos que los contienen.
TNSN97144A1 (fr) Derives 6,6-heterobicycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98084A1 (fr) Derives de macrolides substitues en position c-4
TNSN99162A1 (fr) Derives de quinoleine-2-one a substituant alcynyle nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
HUT65192A (en) Process for producing pyrido-, pyrrolo-, thiazino-, oxazino- and pyrazino benzazepine derivatives and pharmaceutical preparations containing
TNSN97023A1 (fr) Derives de triazole utiles en therapeutique, procedes pour leur preparation et compositions les contenant.
IL117091A (en) Methylphenyloxazolidinone derivatives pharmaceutical compositions containing the same and processes for the preparation threreof
HU9601846D0 (en) Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents
AU6797298A (en) Halo-alkoxycarbonyl prodrugs
IL148563A0 (en) Calcium complex of phosphorus containing ethylenediamine derivatives
IL154755A0 (en) Antitumor theraphy comprising distamycin derivatives
HK1042430A1 (en) Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents
IL147890A0 (en) Pharmaceutical compositions containing pentafluorobenzenesulfonamide derivatives
AP2001002369A0 (en) Pharmaceutical complex.
FR2450840A1 (fr) Complexes orthophosphates de cis-diammineplatine(ii) utiles comme medicaments et compositions pharmaceutiques les contenant
WO1992019573A3 (en) Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical
TR200000753T2 (tr) Mukabil antifungal ajan için prodrog olarak tetrahidrofuran fosfat ve hidroksi esterleri.
UA40656C2 (uk) Засіб "феррофол" для лікування залізодефіцитної анемії
MX9709001A (es) Composicion farmaceutica preparada por la adicion de un vehiculo saborizante para un medicamento.
TNSN91040A1 (fr) Derives de benzofuranne
UA30361A (uk) Спосіб лікування глікозидної інтоксикації

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20080904

Year of fee payment: 9

PNAN Change of the applicant name, address/residence

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, DE

PBON Lapse due to non-payment of renewal fee

Effective date: 20090907